BUSINESS
CSL to Join Forces with Specialists to Raise Awareness of HAE: Japan President
CSL Behring plans to amp up its efforts to raise awareness for hereditary angioedema (HAE) among Japanese physicians following the launch of Andembry (garadacimab) earlier this month, Japan President Izumi Yoshida told Jiho on April 22. There are said to…
To read the full story
Related Article
- CSL’s New HAE Drug Andembry Now Available in Japan
April 21, 2025
- Izumi Yoshida Named Japan President of CSL Behring
October 2, 2023
BUSINESS
- Marubeni Pharma Seeks New Growth Drivers to Hit FY2035 Sales Goal
July 10, 2026
- Women Hold Nearly 1/4 of Leadership Roles at Japan’s Listed Pharmas and Wholesalers
July 10, 2026
- Expert Welcomes Talvey-Tecvayli Combo for Difficult-to-Treat MM
July 10, 2026
- Axcelead Teams Up with Mitsubishi to Expand Drug Discovery Support Biz
July 10, 2026
- Roche PD-L1 Test Approved for Imfinzi in Endometrial Cancer
July 10, 2026
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…





